Covid-19 vaccine makers Moderna and BioNTech became household names almost overnight. Moderna and BioNTech have spent their ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Kennedy’s newest decision comes amid a string of vaccine pullbacks at the health department in recent months. In May, he said ...

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

Moderna and BioNTech launched their initial public offerings ("IPOs") within one year of each other, with Modena raising $604m at $23 per share in December 2018, and BioNTech raising $150m at $15 ...

Moderna is not asking that courts take the Pfizer-BioNTech COVID-19 vaccine off the market or to stop future sales, in view of the public need for the vaccines. Moderna and Pfizer's vaccines have ...

Moderna stock is worth ~39% more than BioNTech stock, which is a significant amount, but it has always been the higher valued company, and back in September 2021, it was worth 2x more than BioNTech.

London's Court of Appeal on Friday struck down a case filed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), in a bid to ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...